SEAGEN INC. DL-,001 | 127.940 / 0.00% |
Date/Time | 05/26 / 09:43 |
Chg. / Chg.(%) | 0.000 / 0.00% |
Bid | 127.000 / 59 |
Ask | 128.900 / 59 |
Open | 127.940 |
Previous Close | 127.940 |
High | 127.940 |
Low | 127.940 |
Volume [EUR] | - |
Volume [Units] | |
Price fixings | 3 |
ISIN | US81181C1045 |
Security | SGT |
Exchange | gettex |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
München | 126.68 | ![]() |
0 |
Berlin | 126.64 | ![]() |
0 |
Frankfurt | 126.8000 | ![]() |
0 |
Quotrix | 127.6000 | ![]() |
|
Stuttgart | 126.880 | ![]() |
|
Lang & Schwa.. | 127.10 | ![]() |
|
gettex | 127.940 | ![]() |
|
NASDAQ | 136.4700 | ![]() |
1,199,271 |
IEX | 136.41 | ![]() |
76,960 |
Cboe US | 136.24 | ![]() |
39,663 |
London Domes.. | 134.90 | 21 | |
TradeGate | 129.74 | 19 | |
Mexico | 3,254.27 | ![]() |
1,262 |
News
- US mixed upon Biden remarks, Fed input
05/10/2022 / 22:00 - TeleTrader - US opens higher ahead of Biden's inflation remarks
05/10/2022 / 15:31 - TeleTrader - Virtual Conference Brings Young Breast Cancer Survivors Together
03/19/2022 / 12:00 - GlobeNewswire - Press Release: Sanofi and Seagen announce collaboration to develop and commercialize multiple novel antibody-drug conjugates
03/16/2022 / 11:18 - GlobeNewswire - Epygenix Therapeutics Announces Appointment of Darren Cline as CEO
03/15/2022 / 12:00 - GlobeNewswire
Personal area
Click on
to activate push quotes.
